Each capsule contains 25 mcg of slow-release triiodothyronine (T3) and 100 mcg of diiodothyronine (T2). Our “Metabolic Thyroid Optimizer” formulation delivers a synergistic, sustained-release blend for comprehensive thyroid support and metabolic enhancement, harnessing the bioactive potency of T3 and T2 to restore hormonal balance, boost energy production, and optimize fat metabolism while reducing peak-dose fluctuations for improved tolerability and long-term adherence in thyroid management protocols. Triiodothyronine (T3), the primary active form of thyroid hormone derived from peripheral deiodination of thyroxine (T4) in tissues like the liver and kidneys, and its metabolite diiodothyronine (T2), produced via further deiodination, exert their physiological effects by binding to nuclear thyroid hormone receptors (TRα and TRβ), modulating gene transcription to upregulate mitochondrial activity, enhance lipolysis, and promote thermogenesis without the rapid clearance issues of standard formulations. This dual-action mechanism also influences peripheral glucose uptake, supports neuromuscular function, and aids in the resolution of hypothyroid symptoms such as fatigue and cognitive fog, while the slow-release profile ensures steady serum levels to mimic natural circadian rhythms, covering applications from subclinical hypothyroidism to post-thyroidectomy support for holistic endocrine and metabolic wellness.
T3 and T2 are also gaining recognition for their roles in mitigating neurodegenerative risks, enhancing mitochondrial bioenergetics in aging populations, and alleviating symptoms of metabolic syndrome. An essential component in addressing treatment-resistant fatigue and weight management challenges.
